Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma

Here, we discuss the presence and roles of heterogeneity in the development of uveal melanoma. Both genetic and cellular heterogeneity are considered, as their presence became undeniable due to single cell approaches that have recently been used in uveal melanoma analysis. However, the presence of p...

Full description

Saved in:
Bibliographic Details
Published in:Molecular biomedicine 2021-08, Vol.2 (1), p.25-25, Article 25
Main Authors: de Lange, Mark J., Nell, Rogier J., van der Velden, Pieter A.
Format: Article
Language:English
Subjects:
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Cancer
Cloning
Driver mutation
Genotype & phenotype
Heterogeneity
Immune infiltrate
Melanoma
Molecular Medicine
Mutation
Precursor lesion
Review
Stem cells
Tumors
Uveal melanoma
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4915-a61dbb516e2e57145d8c4c4bc9c0fcaf364e1898e39a1a5c8ce910ef1a04cc543
cites cdi_FETCH-LOGICAL-c4915-a61dbb516e2e57145d8c4c4bc9c0fcaf364e1898e39a1a5c8ce910ef1a04cc543
container_end_page 25
container_issue 1
container_start_page 25
container_title Molecular biomedicine
container_volume 2
creator de Lange, Mark J.
Nell, Rogier J.
van der Velden, Pieter A.
description Here, we discuss the presence and roles of heterogeneity in the development of uveal melanoma. Both genetic and cellular heterogeneity are considered, as their presence became undeniable due to single cell approaches that have recently been used in uveal melanoma analysis. However, the presence of precursor clones and immune infiltrate in uveal melanoma have been described as being part of the tumour already decades ago. Since uveal melanoma grow in the corpus vitreous, they present a unique tumour model because every cell present in the tumour tissue is actually part of the tumour and possibly plays a role. For an effective treatment of uveal melanoma metastasis, it should be clear whether precursor clones and normal cells play an active role in progression and metastasis. We propagate analysis of bulk tissue that allows analysis of tumour heterogeneity in a clinical setting.
doi_str_mv 10.1186/s43556-021-00048-x
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_aee7e46399ef45ce9688686aefa60519</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_aee7e46399ef45ce9688686aefa60519</doaj_id><sourcerecordid>2730350426</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4915-a61dbb516e2e57145d8c4c4bc9c0fcaf364e1898e39a1a5c8ce910ef1a04cc543</originalsourceid><addsrcrecordid>eNp9ksFu1DAQhiMEolXpC3BAkbhwCdiOPXEuSKgqbaVKHIAbkjXrnWy9cuzFTqr27fE2bWk5cPLI88834_FfVW85-8i5hk9ZtkpBwwRvGGNSNzcvqkMBIBoNir98Eh9Uxzlvi0h00EuA19VBqxgDqeGw-vXdOgqTG5ytMaxr611wFn3txp0vweRiyHUc6g0Fmh5E5P3sMdVXNFGK-5SbbmsX6vmaSu1IHkMc8U31akCf6fj-PKp-fj39cXLeXH47uzj5ctlY2XPVIPD1aqU4kCDVcanW2korV7a3bLA4tCCJ615T2yNHZbWlnjMaODJprZLtUXWxcNcRt2aX3Ijp1kR05u4ipo3BVIb3ZJCoIwlt39MgVQGB1qABaUBgiveF9Xlh7ebVSGtblpPQP4M-zwR3ZTbx2mhgXdurAvhwD0jx90x5MqPL-41hoDhnI4BrxYTq9r3e_yPdxjmFsiojupaVX5ICikosKptizomGx2E4M3svmMULpnjB3HnB3JSid0-f8Vjy8PNF0C6CXFJhQ-lv7_9g_wCZGMFE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2730350426</pqid></control><display><type>article</type><title>Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma</title><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access</source><source>PubMed Central</source><creator>de Lange, Mark J. ; Nell, Rogier J. ; van der Velden, Pieter A.</creator><creatorcontrib>de Lange, Mark J. ; Nell, Rogier J. ; van der Velden, Pieter A.</creatorcontrib><description>Here, we discuss the presence and roles of heterogeneity in the development of uveal melanoma. Both genetic and cellular heterogeneity are considered, as their presence became undeniable due to single cell approaches that have recently been used in uveal melanoma analysis. However, the presence of precursor clones and immune infiltrate in uveal melanoma have been described as being part of the tumour already decades ago. Since uveal melanoma grow in the corpus vitreous, they present a unique tumour model because every cell present in the tumour tissue is actually part of the tumour and possibly plays a role. For an effective treatment of uveal melanoma metastasis, it should be clear whether precursor clones and normal cells play an active role in progression and metastasis. We propagate analysis of bulk tissue that allows analysis of tumour heterogeneity in a clinical setting.</description><identifier>ISSN: 2662-8651</identifier><identifier>EISSN: 2662-8651</identifier><identifier>DOI: 10.1186/s43556-021-00048-x</identifier><identifier>PMID: 35006486</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Biomedical and Life Sciences ; Biomedical Engineering/Biotechnology ; Biomedicine ; Cancer ; Cloning ; Driver mutation ; Genotype &amp; phenotype ; Heterogeneity ; Immune infiltrate ; Melanoma ; Molecular Medicine ; Mutation ; Precursor lesion ; Review ; Stem cells ; Tumors ; Uveal melanoma</subject><ispartof>Molecular biomedicine, 2021-08, Vol.2 (1), p.25-25, Article 25</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4915-a61dbb516e2e57145d8c4c4bc9c0fcaf364e1898e39a1a5c8ce910ef1a04cc543</citedby><cites>FETCH-LOGICAL-c4915-a61dbb516e2e57145d8c4c4bc9c0fcaf364e1898e39a1a5c8ce910ef1a04cc543</cites><orcidid>0000-0002-5710-9256</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2730350426/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2730350426?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35006486$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Lange, Mark J.</creatorcontrib><creatorcontrib>Nell, Rogier J.</creatorcontrib><creatorcontrib>van der Velden, Pieter A.</creatorcontrib><title>Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma</title><title>Molecular biomedicine</title><addtitle>Mol Biomed</addtitle><addtitle>Mol Biomed</addtitle><description>Here, we discuss the presence and roles of heterogeneity in the development of uveal melanoma. Both genetic and cellular heterogeneity are considered, as their presence became undeniable due to single cell approaches that have recently been used in uveal melanoma analysis. However, the presence of precursor clones and immune infiltrate in uveal melanoma have been described as being part of the tumour already decades ago. Since uveal melanoma grow in the corpus vitreous, they present a unique tumour model because every cell present in the tumour tissue is actually part of the tumour and possibly plays a role. For an effective treatment of uveal melanoma metastasis, it should be clear whether precursor clones and normal cells play an active role in progression and metastasis. We propagate analysis of bulk tissue that allows analysis of tumour heterogeneity in a clinical setting.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering/Biotechnology</subject><subject>Biomedicine</subject><subject>Cancer</subject><subject>Cloning</subject><subject>Driver mutation</subject><subject>Genotype &amp; phenotype</subject><subject>Heterogeneity</subject><subject>Immune infiltrate</subject><subject>Melanoma</subject><subject>Molecular Medicine</subject><subject>Mutation</subject><subject>Precursor lesion</subject><subject>Review</subject><subject>Stem cells</subject><subject>Tumors</subject><subject>Uveal melanoma</subject><issn>2662-8651</issn><issn>2662-8651</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ksFu1DAQhiMEolXpC3BAkbhwCdiOPXEuSKgqbaVKHIAbkjXrnWy9cuzFTqr27fE2bWk5cPLI88834_FfVW85-8i5hk9ZtkpBwwRvGGNSNzcvqkMBIBoNir98Eh9Uxzlvi0h00EuA19VBqxgDqeGw-vXdOgqTG5ytMaxr611wFn3txp0vweRiyHUc6g0Fmh5E5P3sMdVXNFGK-5SbbmsX6vmaSu1IHkMc8U31akCf6fj-PKp-fj39cXLeXH47uzj5ctlY2XPVIPD1aqU4kCDVcanW2korV7a3bLA4tCCJ615T2yNHZbWlnjMaODJprZLtUXWxcNcRt2aX3Ijp1kR05u4ipo3BVIb3ZJCoIwlt39MgVQGB1qABaUBgiveF9Xlh7ebVSGtblpPQP4M-zwR3ZTbx2mhgXdurAvhwD0jx90x5MqPL-41hoDhnI4BrxYTq9r3e_yPdxjmFsiojupaVX5ICikosKptizomGx2E4M3svmMULpnjB3HnB3JSid0-f8Vjy8PNF0C6CXFJhQ-lv7_9g_wCZGMFE</recordid><startdate>20210820</startdate><enddate>20210820</enddate><creator>de Lange, Mark J.</creator><creator>Nell, Rogier J.</creator><creator>van der Velden, Pieter A.</creator><general>Springer Singapore</general><general>Springer Nature B.V</general><general>Springer</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5710-9256</orcidid></search><sort><creationdate>20210820</creationdate><title>Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma</title><author>de Lange, Mark J. ; Nell, Rogier J. ; van der Velden, Pieter A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4915-a61dbb516e2e57145d8c4c4bc9c0fcaf364e1898e39a1a5c8ce910ef1a04cc543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering/Biotechnology</topic><topic>Biomedicine</topic><topic>Cancer</topic><topic>Cloning</topic><topic>Driver mutation</topic><topic>Genotype &amp; phenotype</topic><topic>Heterogeneity</topic><topic>Immune infiltrate</topic><topic>Melanoma</topic><topic>Molecular Medicine</topic><topic>Mutation</topic><topic>Precursor lesion</topic><topic>Review</topic><topic>Stem cells</topic><topic>Tumors</topic><topic>Uveal melanoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Lange, Mark J.</creatorcontrib><creatorcontrib>Nell, Rogier J.</creatorcontrib><creatorcontrib>van der Velden, Pieter A.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Molecular biomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Lange, Mark J.</au><au>Nell, Rogier J.</au><au>van der Velden, Pieter A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma</atitle><jtitle>Molecular biomedicine</jtitle><stitle>Mol Biomed</stitle><addtitle>Mol Biomed</addtitle><date>2021-08-20</date><risdate>2021</risdate><volume>2</volume><issue>1</issue><spage>25</spage><epage>25</epage><pages>25-25</pages><artnum>25</artnum><issn>2662-8651</issn><eissn>2662-8651</eissn><abstract>Here, we discuss the presence and roles of heterogeneity in the development of uveal melanoma. Both genetic and cellular heterogeneity are considered, as their presence became undeniable due to single cell approaches that have recently been used in uveal melanoma analysis. However, the presence of precursor clones and immune infiltrate in uveal melanoma have been described as being part of the tumour already decades ago. Since uveal melanoma grow in the corpus vitreous, they present a unique tumour model because every cell present in the tumour tissue is actually part of the tumour and possibly plays a role. For an effective treatment of uveal melanoma metastasis, it should be clear whether precursor clones and normal cells play an active role in progression and metastasis. We propagate analysis of bulk tissue that allows analysis of tumour heterogeneity in a clinical setting.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>35006486</pmid><doi>10.1186/s43556-021-00048-x</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-5710-9256</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2662-8651
ispartof Molecular biomedicine, 2021-08, Vol.2 (1), p.25-25, Article 25
issn 2662-8651
2662-8651
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_aee7e46399ef45ce9688686aefa60519
source Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access; PubMed Central
subjects Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Cancer
Cloning
Driver mutation
Genotype & phenotype
Heterogeneity
Immune infiltrate
Melanoma
Molecular Medicine
Mutation
Precursor lesion
Review
Stem cells
Tumors
Uveal melanoma
title Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T19%3A13%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Scientific%20and%20clinical%20implications%20of%20genetic%20and%20cellular%20heterogeneity%20in%20uveal%20melanoma&rft.jtitle=Molecular%20biomedicine&rft.au=de%20Lange,%20Mark%20J.&rft.date=2021-08-20&rft.volume=2&rft.issue=1&rft.spage=25&rft.epage=25&rft.pages=25-25&rft.artnum=25&rft.issn=2662-8651&rft.eissn=2662-8651&rft_id=info:doi/10.1186/s43556-021-00048-x&rft_dat=%3Cproquest_doaj_%3E2730350426%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4915-a61dbb516e2e57145d8c4c4bc9c0fcaf364e1898e39a1a5c8ce910ef1a04cc543%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2730350426&rft_id=info:pmid/35006486&rfr_iscdi=true